[Drug regulation in Spain].
作者信息
Rubio Terrés C
机构信息
Laboratorios Lederle, División de Cyanamid Ibérica, SA, Madrid.
出版信息
Med Clin (Barc). 1992 May 16;98(19):741-8.
PMID:1608280
Abstract
摘要
相似文献
1
[Drug regulation in Spain].[西班牙的药品监管]
Med Clin (Barc). 1992 May 16;98(19):741-8.
2
A new era in drug regulation?药品监管的新时代？
Hastings Cent Rep. 2005 May-Jun;35(3):10-1.
3
[The role of the Danish Medical Products Agency in clinical trials].[丹麦药品管理局在临床试验中的作用]
Ugeskr Laeger. 2003 Apr 14;165(16):1653-6.
4
[The 1990 drug law. Its implications for the clinical doctor].[1990年药品法。其对临床医生的影响]
Med Clin (Barc). 1992 Feb 22;98(7):263-9.
5
The regulation of investigational drugs.研究用药物的监管
N Engl J Med. 1989 Feb 2;320(5):281-8. doi: 10.1056/NEJM198902023200504.
6
Tooth-whitening directive finally being put to the vote.牙齿美白指令最终付诸表决。
J Ir Dent Assoc. 2010 Jun-Jul;56(3):122-3.
7
Post-market approval surveillance: a call for a more integrated and comprehensive approach.上市后批准后监测：呼吁采取更综合全面的方法。
Circulation. 2004 Jun 29;109(25):3073-7. doi: 10.1161/01.CIR.0000134694.78653.B6.
8
Health authorities and drug utilization studies.卫生当局与药物利用研究。
WHO Reg Publ Eur Ser. 1993;45:147-67.
9
Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee.积极管理上市药品风险：欧洲药品管理局药物警戒风险评估委员会的经验
Nat Rev Drug Discov. 2014 May;13(5):395-7. doi: 10.1038/nrd3713-c1. Epub 2014 Apr 22.
10
European Union clinical trials directive.欧盟临床试验指令
Bull Med Ethics. 2001 Jul(169):13-24.
Zotero 插件